mycophenolate mofetil

(redirected from Myfortic)
Also found in: Medical.
Related to Myfortic: Prograf
Translations

mycophenolate mofetil

n micofenolato de mofetilo
References in periodicals archive ?
Tenders are invited for Tab Myfortic 360 Mg Tab Mycophenolic Acid/ Mycophenolate
M2 EQUITYBITES-November 24, 2015-Novartis Pharmaceuticals to pay USD390m to resolve civil suit regarding Exjade and Myfortic drugs
M2 PHARMA-November 24, 2015-Novartis Pharmaceuticals to pay USD390m to resolve civil suit regarding Exjade and Myfortic drugs
and a government lawsuit states that, from 2005 to 2013, Novartis persuaded 20 pharmacies to switch thousands of kidney transplant patients to its immunosuppressant drug Myfortic by providing kickbacks in the form of discounts and rebates.
Teva has applied to the FDA for permission to market copies of delayed-release Myfortic before the three Novartis patents expire, Novartis said in a complaint filed in federal court in Wilmington, Delaware.
Novartis, AG, Basel, Switzerland, has filed a lawsuit against Teva Pharmaceutical Industries, Ltd, (Petach Tikva, Israel-based Teva) in a US court alleging infringement of patents for Myfortic, its generic drug to prevent kidney transplant rejection.
In fact, the REMS being developed for CellCept and Myfortic call for physician training and certification and a pregnancy registry, according to an FDA statement.
GlaxoSmithKline Plc and US regulators said on Thursday they had notified healthcare professionals that a type of anemia has been reported in some patients treated with transplant drug Myfortic.
CellCept is approved for preventing heart, liver, and kidney trans plant rejection; Myfortic is approved for preventing kidney transplant rejection.
Women taking CellCept and Myfortic and who arc planning to become pregnant should also talk with their doctors about the risks involved and whether alternative immunosuppressive agents can be considered," according to the release.
5 mg Mycophenolic Acid Delayed-Release Myfortic Tablets, 180 mg, 360 mg Delayed-Release Tablets Telmisartan and Amlodipine Tablets, Twynsta Tablets 40 mg/5 mg, 40 mg/10 mg, 80 mg/5 mg, 80 mg/10 mg Doxercalciferol Capsules, 1 mcg, 2.
A Medicare Advantage (MA) plan covered cyclosporine under its Part B benefit but required prior authorization for Myfortic which is also Part B covered.